AprilBio Co.,Ltd. (KOSDAQ: A397030)
Health Care · Biotechnology · KR
₩14,560.00
-14.45% today · -55.7% 1Y
AprilBio Co.,Ltd. (KOSDAQ: A397030) operates in the Biotechnology industry within the Health Care sector. The company is valued at $297.93M.
Over the last twelve months the share price has lost 55.7%, trading between 14.51K and 76.70K.
Tweenvest scores AprilBio Co.,Ltd. across four factors: quality 43/100, value 55/100. Its strongest factor is value.
A397030 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $297.93M
- Revenue (TTM)
- $468.39K
- P/E
- —
- EPS
- -390.48
- Dividend yield
- —
- Beta (5Y)
- 1.61
- 52-week high
- ₩76,700.00
- 52-week low
- ₩14,510.00
- Avg volume (3M)
- —
- Shares outstanding
- 27.51M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Orum Therapeutics, Inc.KOSDAQ: A475830 | $311.80M | ₩19,270.00 | -8.89% |
| Benitec Biopharma Inc.NasdaqCM: BNTC | $309.41M | $9.07 | +2.25% |
| TCM Biotech International Corp.TWSE: 4169 | $306.45M | NT$147.50 | -2.64% |
| Perspective Therapeutics, Inc.NYSEAM: CATX | $303.64M | $2.52 | -5.26% |
| Curocell Inc.KOSDAQ: A372320 | $296.19M | ₩26,150.00 | +13.70% |
| Clover Biopharmaceuticals, Ltd.SEHK: 2197 | $295.33M | HK$1.79 | -12.71% |
| X4 Pharmaceuticals, Inc.NasdaqCM: XFOR | $288.52M | $2.82 | -3.09% |
| CytoDyn Inc.OTCPK: CYDY | $287.21M | $0.20 | -11.89% |
Figures last refreshed Oct 11, 2026.